Sotera Health (NASDAQ:SHC) Receives Average Rating of “Moderate Buy” from Brokerages

Sotera Health (NASDAQ:SHC) has received a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $16.08.

A number of research analysts have recently commented on the company. The Goldman Sachs Group began coverage on Sotera Health in a report on Friday, December 6th. They set a “neutral” rating and a $14.00 price target for the company. Royal Bank of Canada restated an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. Finally, Citigroup upped their price objective on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th.

Sotera Health Price Performance

Shares of Sotera Health stock opened at $13.39 on Friday. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The firm has a fifty day simple moving average of $13.79 and a 200-day simple moving average of $14.38. The stock has a market capitalization of $3.79 billion, a price-to-earnings ratio of 53.56 and a beta of 1.92. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.44.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The firm had revenue of $285.47 million for the quarter, compared to the consensus estimate of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The firm’s revenue was up 8.5% on a year-over-year basis. During the same quarter last year, the company earned $0.18 earnings per share. On average, sell-side analysts expect that Sotera Health will post 0.61 earnings per share for the current year.

Institutional Investors Weigh In On Sotera Health

Several large investors have recently modified their holdings of the stock. Darsana Capital Partners LP grew its position in Sotera Health by 716.9% in the third quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company’s stock valued at $334,167,000 after acquiring an additional 17,560,636 shares during the period. Sessa Capital IM L.P. boosted its stake in shares of Sotera Health by 46.5% in the 3rd quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock valued at $105,220,000 after purchasing an additional 2,000,000 shares in the last quarter. State Street Corp grew its holdings in shares of Sotera Health by 18.5% in the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company’s stock worth $68,918,000 after purchasing an additional 644,236 shares during the last quarter. Maverick Capital Ltd. increased its position in shares of Sotera Health by 3.5% during the 3rd quarter. Maverick Capital Ltd. now owns 3,497,367 shares of the company’s stock worth $58,406,000 after purchasing an additional 118,353 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in Sotera Health by 19.4% during the 3rd quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock valued at $46,026,000 after purchasing an additional 447,186 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.